Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Anti-Borrelia burgdorferi US Westernblot (IgG)

K-Number: K161513 · 2016-08-25

ApplicantEuroimmun US
Decision Date2016-08-25
Product CodeLSR
Advisory CommitteeMI
DecisionSubstantially Equivalent

Device Summary

Anti-Borrelia burgdorferi US Westernblot (IgG) is a medical device manufactured by Euroimmun US. It received FDA 510(k) clearance on 2016-08-25 under approval number K161513. The device is classified under product code LSR. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Anti-Borrelia burgdorferi US Westernblot (IgG)?

Anti-Borrelia burgdorferi US Westernblot (IgG) is a medical device that received FDA 510(k) clearance on 2016-08-25. It is manufactured by Euroimmun US. The 510(k) number is K161513.

When was Anti-Borrelia burgdorferi US Westernblot (IgG) approved by the FDA?

Anti-Borrelia burgdorferi US Westernblot (IgG) received FDA 510(k) clearance on 2016-08-25, under approval number K161513.

What company makes Anti-Borrelia burgdorferi US Westernblot (IgG)?

Anti-Borrelia burgdorferi US Westernblot (IgG) is manufactured by Euroimmun US.

What is the FDA product code for Anti-Borrelia burgdorferi US Westernblot (IgG)?

The FDA product code for Anti-Borrelia burgdorferi US Westernblot (IgG) is LSR.

Related Clinical Trials

Related Devices (Code: LSR)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.